Rockville, Md. — The Association of Community Cancer Centers (ACCC) and Advisory Board’s Oncology Roundtable announced today their collaboration to launch a comprehensive survey that will capture the successes and challenges cancer programs across the country are facing in the current healthcare environment. Pfizer Oncology provides funding and support to ACCC for the “Trending Now in Cancer Care” survey.
“This is the eighth year of our ‘Trends’ survey, and ACCC is very excited to work with Advisory Board to take the survey to the next level and offer a fundamentally critical look at cancer care issues that are affecting both patients and cancer programs today”, Christian Downs, ACCC Executive Director notes. “By taking the pulse on issues such as program mergers and acquisitions, clinical pathways usage, and precision medicine and immunotherapy, ACCC can continue to provide needed resources to its members.”
Additional hot topics addressed in the “Trending Now in Cancer Care” survey include:
Findings will help cancer programs assess their strengths and weaknesses. Survey participants will receive a customized report, comparing their data to national benchmarks. ACCC and Oncology Roundtable members who complete the survey will also receive access to interactive tools and cohort data. ACCC and Advisory Board will use survey data to assess current member needs.
“The Oncology Roundtable is thrilled to team with the ACCC on this survey,” states Lindsay Conway, Managing Director for the Oncology Roundtable at Advisory Board. “This collaboration will further our understanding of how cancer providers across the country are adapting to a changing health care environment, as well as help us identify strategies to ensure cancer programs’ success in the coming years.”
The “Trending Now in Cancer Care” survey is open to all oncology programs in the United States. Respondents do not need to be members of ACCC or the Oncology Roundtable to participate. Any members of an organization’s multidisciplinary cancer team, including, cancer program executives and administrators, clinical staff, and physicians are encouraged to participate.
The survey will be available online for approximately four weeks, beginning July 24, 2017. It is estimated that the survey will take approximately 20-30 minutes to complete. Questions are multiple choice.
About Advisory Board
Advisory Board is a best practices firm that uses a combination of research, technology, and consulting to improve the performance of 4,500+ health care organizations. As the health care business of The Advisory Board Company (NASDAQ: ABCO), Advisory Board forges and finds the best new ideas and proven practices from its network of thousands of leaders, then customizes and hardwires them into every level of member organizations, creating enduring value. For more information, visit www.advisory.com.
December 21, 2021
December 21, 2021
September 13, 2021
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
